MTCH2 and Fat Metabolism: Why Mice Accumulated Less Fat

MTCH2 and fat metabolism have an unexpected connection. Mice genetically engineered to lack this protein specifically in their fat cells continued eating roughly the same amount as ordinary mice. Yet when placed on a high-fat diet, they gained less weight, accumulated less body fat, and expended more energy.

The difference was not explained by eating less or moving more. It came from changes in how cells handled fatty acids, including a molecular mechanism that controls their entry into mitochondria, where they can be used as fuel.

Two related studies published in 2025, one in The EMBO Journal and the other in Nature Communications, reveal a more active role for fat tissue in regulating energy balance. Beyond storing surplus calories, fat cells help determine how much energy the body uses.

Same Food Intake, Less Weight Gain

In the Nature Communications study, an international research team investigated MTCH2, a protein located in the outer membrane of mitochondria.

Mitochondria generate much of the energy cells need by processing nutrients, including products derived from carbohydrates and fats.

MTCH2 was already known to participate in mitochondrial regulation, but its precise role in fat metabolism remained incompletely understood.

To examine its physiological effects, researchers generated mice in which the Mtch2 gene was selectively disabled in adipocytes, the specialized cells that store fat.

Under a standard diet, genetically modified and control mice showed similar weight-gain patterns. The difference emerged when the animals were fed a high-fat diet.

Mice lacking MTCH2 in their fat cells gained less weight despite consuming similar amounts of food.

Metabolic measurements revealed increased energy expenditure. This was not accompanied by increased locomotor activity, suggesting that the animals were using more energy without simply becoming more physically active.

After 13 weeks on the high-fat diet, the modified mice had lower fat mass while maintaining lean mass comparable to that of control animals.

They also showed improved glucose tolerance and lower circulating cholesterol levels.

These findings pointed toward a change in fuel metabolism rather than a reduction in calorie intake.

How MTCH2 Restrains Fat Oxidation

The researchers traced the effect to a molecular system that controls how fatty acids enter mitochondria.

Long-chain fatty acids require a specialized transport mechanism before they can be efficiently broken down inside mitochondria for energy production.

One of its key regulators is an enzyme called carnitine palmitoyltransferase 1, or CPT1.

CPT1 helps prepare fatty acids for transport into mitochondria. Its activity is normally restrained by a molecule called malonyl-CoA, which acts as a metabolic brake.

The team discovered that MTCH2 physically interacts with CPT1 and influences how strongly this brake affects the enzyme.

When MTCH2 was absent, CPT1 became less sensitive to inhibition by malonyl-CoA.

As a result, fatty acid oxidation increased, allowing cells to use more fatty acids as fuel.

This effect was demonstrated in cultured mature adipocytes of both human and mouse origin.

The increase in energy expenditure was also independent of UCP1, a protein best known for its role in heat production by brown adipose tissue.

These observations identify MTCH2 as a negative regulator of fat utilization, providing a molecular explanation for some of the changes observed in genetically modified animals.

Why New Fat Cells Struggled to Develop Without MTCH2

A related study in The EMBO Journal, led by Sabita Chourasia and Atan Gross, revealed another consequence of losing MTCH2.

The researchers first deleted the gene in cultured human HeLa cells and followed changes in cellular metabolism over time.

Without MTCH2, the cells showed increased mitochondrial respiration and greater utilization of nutrients, including fatty acids, carbohydrates, and amino acids. Their energy balance and metabolic environment also changed substantially.

The researchers then investigated whether these effects could influence the formation of new fat cells.

They used a mouse-derived preadipocyte cell line, a standard laboratory model in which immature precursor cells can be induced to mature into fat-storing adipocytes.

The difference was striking.

After six days, approximately 80–90% of normal precursor cells had differentiated into adipocytes. Among cells lacking MTCH2, only about 5–10% had done so.

The modified cells also developed substantially fewer lipid droplets, the intracellular structures used to store fat.

The explanation appears to involve the energy-intensive process of cellular differentiation.

A precursor cell must synthesize new molecules, reorganize its internal structures, activate a specialized genetic program, and accumulate lipids to become a mature adipocyte.

All these changes depend on an appropriate balance between energy production, nutrient availability, and the biochemical reactions that support biosynthesis.

Deleting MTCH2 shifted metabolism toward increased fuel consumption and disrupted several conditions required for normal differentiation.

The study also revealed an important complication.

In HeLa cells, loss of MTCH2 did not simply eliminate intracellular fat. Certain storage lipids actually increased, while membrane lipid levels decreased.

Increased fatty acid utilization therefore does not automatically mean that every cellular lipid pool shrinks. Cells can simultaneously burn more fuel and redistribute their remaining lipid resources.

The findings highlight the distinction between fat oxidation, lipid storage, and the developmental process through which new fat cells form.

Could MTCH2 Become a Treatment Target?

Together, the studies suggest that MTCH2 may be an attractive target for influencing energy expenditure and fat metabolism.

But genetically removing a protein in an experimental system is very different from developing a safe treatment.

No clinical trial has established that inhibiting MTCH2 causes safe, sustained weight loss in humans.

The reduced weight gain was demonstrated in genetically modified mice. The dramatic reduction in adipocyte differentiation came from a mouse-derived laboratory cell line, not from an experiment showing that human fat tissue stops producing new adipocytes.

There are also biological reasons for caution.

MTCH2 participates in other essential cellular functions, including mitochondrial organization and pathways involved in programmed cell death. Broad inhibition could therefore have unintended effects in different tissues.

Furthermore, healthy adipose tissue serves vital metabolic functions. It safely stores excess energy, produces hormones, and helps regulate glucose and lipid balance.

Preventing the formation of new fat cells is not automatically beneficial. If adipose tissue cannot expand appropriately, excess lipids may accumulate in organs where they can contribute to metabolic disease.

A more promising long-term strategy might involve selectively modifying specific MTCH2-dependent pathways rather than eliminating the protein throughout the body.

The central finding is nevertheless a meaningful addition to our understanding of energy balance.

Most discussions of weight management emphasize how much food enters the body. These experiments show that changing the metabolic behavior of adipocytes can also alter fat accumulation, even when calorie intake remains comparable.

In the mouse experiments, the decisive difference was not the amount of energy consumed, but how the animals used it.